SCHEMBL30964652

SCHEMBL30964652

Cc1cccc(Oc2ccc(-n3c(=O)[nH]c4cccnc43)cn2)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.46
DAO P14920 1/20 0.39
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
GABRA4 P48169 1/20 0.38
GABRE P78334 1/20 0.38
GABRA6 Q16445 1/20 0.38
GABRG1 Q8N1C3 1/20 0.38
GABRG3 Q99928 1/20 0.38
GABRQ Q9UN88 1/20 0.38
LMNA P02545 1/20 0.38
OXTR P30559 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23927091 0.81 ALDH1A1 (0.43) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL23927079 0.81 HTR1A (0.39) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL30079061 0.81 OXTR (0.37) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL23927055 0.81 OXTR (0.37) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL23927030 0.80 DRD1 (0.40) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL30079049 0.80 DRD1 (0.40) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL23952721 0.79 GABRP (0.39) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL25025704 0.79 GABRP (0.36) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL25025657 0.79 DRD1 (0.41) DAOGABRPGABRDGABRA1GABRB1
SCHEMBL30794092 0.79 DRD1 (0.41) DAOGABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125381-A1 NOVEL Kv3 CHANNEL MODULATORS MERCK SHARP & DOHME LLC (US) 2026-05-07 US disclosed
EP-4604945-A2 NOVEL KV3 CHANNEL MODULATORS Merck Sharp & Dohme LLC (US) 2025-08-27 EP disclosed
WO-2024086061-A2 NOVEL KV3 CHANNEL MODULATORS MERCK SHARP & DOHME LLC (US) 2024-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125381-A1 NOVEL Kv3 CHANNEL MODULATORS KCNN3, KCNA3, KCNQ3 KEAP1 1499/4885DAO 4400/4885GABRP 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.